Evidence map›Paper›PMID 41080761›Full record

ArticleNon-coding RNA research2026

Circadian rhythm-related miR-6883-5p suppresses enzalutamide-resistant prostate cancer.

Wenchang Yue, Chao Li, Tao Wang, Jiawei You, Jiale Sun, Jiapeng Liu, Ashutosh K Tewari, Kyprianou Natasha, Mariana G Figueiro, Jianquan Hou and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Non-coding RNA research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Wenchang YueDepartment of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, the United States of America.
Chao LiCambridge-Su Genomic Resource Center, Suzhou Medical College of Soochow University, Jiangsu, 215123, China.
Tao WangCambridge-Su Genomic Resource Center, Suzhou Medical College of Soochow University, Jiangsu, 215123, China.
Jiawei YouDepartment of Urology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, China.
Jiale SunDepartment of Urology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, China.
Jiapeng LiuKey Laboratory of RNA Innovation Science and Engineering, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, 200031, China.
Ashutosh K TewariDepartment of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, the United States of America.
Kyprianou NatashaDepartment of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, the United States of America.
Mariana G FigueiroDepartment of Population Health Science and Policy, Light and Health Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, the United States of America.
Jianquan HouDepartment of Urology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, China.
Babu J PadanilamDepartment of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, the United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing incidence of prostate cancer (PCa), particularly the emergence of treatment-resistant castration-resistant prostate cancer (CRPC), has intensified research efforts to address this lethal disease. Circadian rhythm gene alterations have been identified as critical factors influencing PCa progression and treatment resistance, warranting further investigation into their roles in PCa biology. In this study, we identified a significant downregulation of

Indexed as

AR-V7Circadian rhythmEnzalutamide resistanceMicroRNAPER1Prostate cancer

Identifiers

PMID41080761
PMCPMC12510047

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.